Sysmex accuses 13 Beckman Coulter instruments of infringing 11 claims in the patent, which covers a system analyzer and a computer program.
A court in San Diego has stated that part of the suit between Quidel and Beckman is void as a matter of law.
The classification indicates a reasonable probability that the use of, or exposure to, a recalled product will cause serious adverse health consequences or death.
Within diagnostics, Beckman Coulter saw core revenue growth in the low-single digits, while Cepheid was up in the double digits for the quarter.
The Canadian regulator gave Medical Device License approval to Beckman Coulter's DxH 900 Hematology Analyzer and its Early Sepsis Indicator.
The test detects and quantifies hepatitis C virus RNA and can be performed in approximately one hour.
Testing with Cepheid's molecular TB assay can shorten the amount of time suspected patients need to be isolated and save thousands of dollars per patient.
Since introducing new clinical platforms last year, Sciex has launched an automated sample prep system while Thermo Fisher has begun customer beta testing.